Key Benefits
Intiflo 0.75mg/100ml Injection contains Eptifibatide, which belongs to the monoclonal anti-glycoprotein IIb/IIIa receptor antibodies class. It works by blocking the glycoprotein IIb/IIIa receptor’s activity, thereby preventing platelet aggregation. This causes inhibition of fibrinogen binding, reducing the chance of blood clot formation. Intiflo 0.75mg/100ml Injection results in reducing the risk of cardiovascular events like myocardial infarction (heart attack) and other cardiac events.
Directions for Use
Side Effects
- Bleeding
- Nausea
- Headache
- Abdominal pain
- Hypotension
- Vomiting
- Dizziness
- Low platelet count
- Pain at the site of injection